Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
It has recently become clear that proteins associated with neurodegenerative disorders can be selectively incorporated into intraluminal vesicles of multivesicular bodies and subsequently released within exosomes. Multiple lines of research support a neuroprotective role for cystatin C in Alzheimer’s disease (AD). Herein we demonstrate that cystatin C, a protein targeted to the classical secretory pathway by its signal peptide sequence, is also secreted by mouse primary neurons in association with exosomes. Immunoproteomic analysis using SELDI TOF MS revealed the presence in exosomes of at least 9 different cystatin C glycoforms. Moreover, the over-expression of familial AD-associated presenilin 2 mutations (PS2 M239I and PS2 T122R) resulted in reduced levels of all cystatin C forms (native and glycosylated) and of amyloid-β precursor protein (APP) metabolites within exosomes. A better understanding of the mechanisms involved in exosomal processing and release may have important implications for the fight against AD and other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Exosomes are released by cultured cortical neurones
Fauré, J., Lachenal, G., Court, M., Hirrlinger, J., Chatellard-Causse, C., Blot, B., Grange, J., Schoehn, G., Goldberg, Y., Boyer, V., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.12.003 · Cited by 896
Huh, C. G., Håkansson, K., Nathanson, C. M., Thorgeirsson, U. P., Jonsson, N., Grubb, A., Abrahamson, M., & Karlsson, S. (1999) · Molecular Pathology · doi:10.1136/mp.52.6.332 · Cited by 119
Research works printed but not linked: 30
- Abrahamson, 1987, Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C, FEBS Lett., 216, 229, 10.1016/0014-5793(87)80695-6 · DOI · Paper page
- Belting, 2008, Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease, J. Cell Biol., 183, 1187, 10.1083/jcb.200810038 · DOI · Paper page
- Benussi, 2005, Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation, Exp. Cell Res., 308, 78, 10.1016/j.yexcr.2005.04.021 · DOI
- Binetti, 2003, A typical dementia associated with a novel presenilin-2 mutation, Ann. Neurol., 54, 832, 10.1002/ana.10760 · DOI · Paper page
- Cho, 2005, Exosomes: a new delivery system for tumor antigens in cancer immunotherapy, Int. J. Cancer, 114, 613, 10.1002/ijc.20757 · DOI · Paper page
- Dahl, 2004, Demonstration of multiple novel glycoforms of the stem cell survival factor CCg, J. Neurosci. Res., 77, 9, 10.1002/jnr.20084 · DOI
- Dai, 2008, Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, Mol. Ther., 16, 782, 10.1038/mt.2008.1 · DOI · Paper page
- Ekström, 2008, Internalization of cystatin C in human cell lines, FEBS J., 275, 4571, 10.1111/j.1742-4658.2008.06600.x · DOI · Paper page
- Février, 2004, Exosomes: endosomal-derived vesicles shipping extracellular messages, Curr. Opin. Cell Biol., 16, 415, 10.1016/j.ceb.2004.06.003 · DOI · Paper page
- Ghidoni, 2007, Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons, Neurobiol. Aging, 28, 371, 10.1016/j.neurobiolaging.2006.01.007 · DOI
- Ghidoni, 2008, Exosomes: the Trojan horses of neurodegeneration, Med. Hypotheses, 70, 1226, 10.1016/j.mehy.2007.12.003 · DOI
- Ghidoni, 2009, Novel T719P AbetaPP mutation unbalances the relative proportion of amyloid-beta peptides, J. Alzheimers Dis., 10.3233/JAD-2009-1142 · DOI · Paper page
- Kaeser, 2007, Cystatin C modulates cerebral beta-amyloidosis, Nat. Genet., 39, 1437, 10.1038/ng.2007.23 · DOI · Paper page
- Korant, 1985, Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells, Biochem. Biophys. Res. Commun., 127, 1072, 10.1016/S0006-291X(85)80054-1 · DOI
- Levy, 2008, Cystatin C: a potential target for Alzheimer's treatment, Expert Rev. Neurother., 8, 687, 10.1586/14737175.8.5.687 · doi:10.1586/14737175.8.5.687
- Levy, 2001, Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer's disease patients, J. Neuropathol. Exp. Neurol., 60, 94, 10.1093/jnen/60.1.94 · DOI · Paper page
- Levy, 2006, The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models, Brain Pathol., 16, 60, 10.1111/j.1750-3639.2006.tb00562.x · DOI · Paper page
- Mi, 2007, Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models, Nat. Genet., 39, 1440, 10.1038/ng.2007.29 · DOI · Paper page
- Palmer, 2001, Cell culture. Progenitor cells from human brain after death, Nature, 411, 42, 10.1038/35075141 · DOI · Paper page
- Sastre, 2004, Binding of cystatin C to Alzheimer's amyloid β inhibits amyloid fibril formation, Neurobiol. Aging, 25, 1033, 10.1016/j.neurobiolaging.2003.11.006 · DOI
- Schorey, 2008, Exosome function: from tumor immunology to pathogen biology, Traffic, 9, 871, 10.1111/j.1600-0854.2008.00734.x · DOI · Paper page
- Selkoe, 1989, Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease, Cell, 58, 611, 10.1016/0092-8674(89)90093-7 · DOI
- Sharples, 2008, Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes, FASEB J., 22, 1469, 10.1096/fj.07-9357com · DOI · Paper page
- Sundelöf, 2008, Serum cystatin C and the risk of Alzheimer's disease in elderly men, Neurology, 71, 1072, 10.1212/01.wnl.0000326894.40353.93 · DOI · Paper page
- Taupin, 2000, FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor, Neuron, 28, 385, 10.1016/S0896-6273(00)00119-7 · DOI · Paper page
- Vella, 2008, The role of exosomes in the processing of proteins associated with neurodegenerative diseases, Eur. Biophys. J., 37, 323, 10.1007/s00249-007-0246-z · DOI · Paper page
- Viaud, 2008, Exosomes for the treatment of human malignancies, Horm. Metab. Res., 40, 82, 10.1055/s-2007-1022548 · DOI
- Vingtdeux, 2007, Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies, J. Biol. Chem., 282, 18197, 10.1074/jbc.M609475200 · DOI · Paper page
- Vinters, 1990, Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease, Am. J. Pathol., 137, 233
- Zhang, 2009, Presenilins are essential for regulating neurotransmitter release, Nature, 460, 632, 10.1038/nature08177 · DOI · Paper page
Cited by
Lachenal, G., Pernet-Gallay, K., Chivet, M., Hemming, F. J., Belly, A., Bodon, G., Blot, B., Haase, G., Goldberg, Y., & Sadoul, R. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.11.004 · Cited by 593
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553
Clinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 450
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Signaling Pathways in Exosomes Biogenesis, Secretion and Fate
Urbanelli, L., Magini, A., Buratta, S., Brozzi, A., Sagini, K., Polchi, A., Tancini, B., & Emiliani, C. (2013) · Genes · doi:10.3390/genes4020152 · Cited by 355
Metadata
- Authors
- Ghidoni, R., Paterlini, A., Albertini, V., Glionna, M., Monti, E., Schiaffonati, L., Benussi, L., Levy, E., & Binetti, G.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 32
- Issue
- 8
- Pages
- 1435-1442
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2026528573
- Cited by
- 111
- References
- 3
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.08.013
- The paper
- Ghidoni, R., Paterlini, A., Albertini, V., Glionna, M., Monti, E., Schiaffonati, L., Benussi, L., Levy, E., & Binetti, G. (2011). Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.08.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.